Why invest in Bionxt

  • Transformative Drug Delivery Solutions: Our advanced oral dissolvable film (ODF) and transdermal patches offer patients a fast, convenient, and more effective way to receive critical medications.
  • High-Growth Market Potential: BioNxt targets significant global markets with strong demand, projected to grow from $1.97 trillion in 2024 to $3.18 trillion by 2034.
  • Strategic IP Portfolio: Our robust patent protection and orphan drug status provide market exclusivity and competitive advantages.
  • Accelerated Path to Market: Using approved APIs, we streamline development through bioequivalence studies, expediting regulatory processes and reducing time-to-market.
  • Experienced Leadership & R&D: Our team includes leading experts in biosciences, backed by specialized R&D capabilities in Germany.

Join our Journey

BioNxt is driven by a mission to enhance patient compliance and quality of life through next-generation drug delivery systems. Our focus is on neurodegenerative and autoimmune diseases—fields with high unmet medical needs and significant commercial potential.

Join us on this journey as we work towards transforming the landscape of patient care and drug delivery.

Investor & Media Contact
Hugh Rogers, CEO
hrogers@bionxt.com
+1 604 250 6162

For further information, visit our filings and follow us on LinkedIn and Instagram

Lab Techs looking at a computer

Get Exclusive BioNxt Updates & Insights

Subscribe to our newsletter for the latest breakthroughs, market insights, and updates on BioNxt’s innovative therapies. Plus, receive instant access to our Corporate Presentation to explore our vision, strategy, and pipeline.

Unsubscribe anytime. View our Privacy Policy for additional information.

Latest Press Releases

View All Press Releases

Stock Information

THE CSE logo

Trading Symbol: BNXT

otc markets vector logo

Trading Symbol: BNXTF

Frankfurt Stock Exchange

Trading Symbol: BXT

Legal Council

McMillan LLP

Royal Centre, Suite 1500
1055 West Georgia Street,
PO Box 11117
Vancouver, BC V6E 4N7
Canada

Auditor

Davidson & Company

609 Granville Street, Suite 1200
P.O. Box 10372, Pacific Centre
Vancouver, BC V7Y 1G6
Canada

Transfer Agent

Computershare Trust
Company of Canada

510 Burrard Street
Vancouver, BC V6C 3B9
Canada

Scientist looking in magnifying glass XPhyto